Moderna Inc. said that a new analysis of the late-stage clinical trial of its Covid-19 vaccine found a higher rate of breakthrough cases in people who got shots early in the study.
from NDTV News - Topstories https://ift.tt/3CgrjMZ
from NDTV News - Topstories https://ift.tt/3CgrjMZ
Comments
Post a Comment